Filed before 2025Filed 16 May 2018
Cyteir Therapeutics, Inc. has sold $5.83M so far
Cyteir Therapeutics, Inc., a biotech company based in Cambridge, MA, has sold $5.83M so far in its equity round, according to a filing dated 16 May 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 16 May 2018
- First filed
- 28 March 2018
- Round
- Equity round (amended filing)
- Amount sold
- $5.83M
- Offering size
- $35M
- Investors so far
- 12
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 48% of the 1,729 tracked raises with an amount filed in 2018, and than 36% of the 160 in biotech.
Cyteir Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Feb 2021 | New filing | $80M | Another raise |
| 15 Oct 2019 | New filing | $20.2M | Another raise |
| 16 May 2018 | Amended filing | $5.83M | This raise |
| 28 Mar 2018 | New filing | $4.82M | This raise |
More with Lightstone Ventures on the board
- Imperative Care, Inc.$111M
- Apreo Health, Inc.$81.8M
- Allay Therapeutics, Inc.$45M
- Cala Health, Inc.$48.2M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.